Dennis Weaver - 31 Aug 2021 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Role
Chief Clinical Officer
Signature
/s/ Allein Sabel, Attorney-in-Fact
Issuer symbol
OSCR
Transactions as of
31 Aug 2021
Net transactions value
-$52,090
Form type
4
Filing time
02 Sep 2021, 19:06:51 UTC
Previous filing
20 Aug 2021
Next filing
03 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OSCR Class A Common Stock Options Exercise +8,333 +49018% 8,350 01 Sep 2021 Direct F1
transaction OSCR Class A Common Stock Sale $52,090 -3,027 -36% $17.21 5,323 01 Sep 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSCR Restricted Stock Units Award $0 +32,072 +40% $0.000000 112,251 31 Aug 2021 Class A Common Stock 32,072 Direct F1, F4
transaction OSCR Stock Option Award $0 +75,202 +40% $0.000000 263,210 31 Aug 2021 Class A Common Stock 75,202 $15.59 Direct F5
transaction OSCR Restricted Stock Units Options Exercise $0 +8,333 $0.000000* 0 01 Sep 2021 Class A Common Stock 8,333 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the settlement of previously granted equity awards.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.15 to $17.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F4 The restricted stock units will vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021.
F5 The options will vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021.
F6 The restricted stock units were granted in January 2021, are fully vested and settled on September 1, 2021.